Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Smart biomaterials that guide tissue repair are key for future medical treatments.

Future acne treatments should aggressively target inflammation to prevent scarring.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Most low-level light therapy studies did not accurately report how light was measured, affecting treatment reliability.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Some medications can cause acne, and stopping these drugs is the main treatment.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Vitamins A, B3, C, D, and E can improve skin health and immunity.